9 Has a concurrent disease or condition or laboratory abnormality that in the view of the investigator places the subject at high risk of poor treatment compliance or of not completing the study or would interfere with study participation or introduces additional safety concerns e.g. diabetes mellitus other concurrent neurological or psychiatric disorders 